Persistent Sepsis-Induced Hypotension without Hyperlactatemia: A Distinct Clinical and Physiological Profile within the Spectrum of Septic Shock

Glenn Hernandez, Alejandro Bruhn, Ricardo Castro, Cesar Pedreros, Maximiliano Rovegno, Eduardo Kattan, Enrique Veas, Andrea Fuentealba, Tomas Regueira, Carolina Ruiz, Can Ince, Glenn Hernandez, Alejandro Bruhn, Ricardo Castro, Cesar Pedreros, Maximiliano Rovegno, Eduardo Kattan, Enrique Veas, Andrea Fuentealba, Tomas Regueira, Carolina Ruiz, Can Ince

Abstract

Introduction. A subgroup of septic shock patients will never develop hyperlactatemia despite being subjected to a massive circulatory stress. Maintenance of normal lactate levels during septic shock is of great clinical and physiological interest. Our aim was to describe the clinical, hemodynamic, perfusion, and microcirculatory profiles associated to the absence of hyperlactatemia during septic shock resuscitation. Methods. We conducted an observational study in septic shock patients undergoing resuscitation. Serial clinical, hemodynamic, and perfusion parameters were registered. A single sublingual microcirculatory assessment was performed in a subgroup. Patients evolving with versus without hyperlactatemia were compared. Results. 124 septic shock patients were included. Patients without hyperlactatemia exhibited lower severity scores and mortality. They also presented higher platelet counts and required less intensive treatment. Microcirculation was assessed in 45 patients. Patients without hyperlactatemia presented higher PPV and MFI values. Lactate was correlated to several microcirculatory parameters. No difference in systemic flow parameters was observed. Conclusion. Persistent sepsis-induced hypotension without hyperlactatemia is associated with less organ dysfunctions and a very low mortality risk. Patients without hyperlactatemia exhibit less coagulation and microcirculatory derangements despite comparable macrohemodynamics. Our study supports the notion that persistent sepsis-induced hypotension without hyperlactatemia exhibits a distinctive clinical and physiological profile.

References

    1. De Backer D. Lactic acidosis. Intensive Care Medicine. 2003;29(5):699–702.
    1. Philp A, Macdonald AL, Watt PW. Lactate—a signal coordinating cell and systemic function. Journal of Experimental Biology. 2005;208(24):4561–4575.
    1. Levy B, Gibot S, Franck P, Cravoisy A, Bollaert PE. Relation between muscle Na+K+ ATPase activity and raised lactate concentrations in septic shock: a prospective study. The Lancet. 2005;365(9462):871–875.
    1. Shapiro NI, Howell MD, Talmor D, et al. Serum lactate as a predictor of mortality in emergency department patients with infection. Annals of Emergency Medicine. 2005;45(5):524–528.
    1. Arnold RC, Shapiro NI, Jones AE, et al. Multicenter study of early lactate clearance as a determinant of survival in patients with presumed sepsis. Shock. 2009;32(1):35–39.
    1. Nichol AD, Egi M, Pettila V, et al. Relative hyperlactatemia and hospital mortality in critically ill patients: a retrospective multi-centre study. Critical Care. 2010;14(1, article R25)
    1. Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Critical Care Medicine. 2003;31(4):1250–1256.
    1. Marchick MR, Kline JA, Jones AE. The significance of non-sustained hypotension in emergency department patients with sepsis. Intensive Care Medicine. 2009;35(7):1261–1264.
    1. Hernandez G, Castro R, Romero C, et al. Persistent sepsis-induced hypotension without hyperlactatemia: is it really septic shock? Journal of Critical Care. 2011;26(4):435.e9–435.e14.
    1. Dellinger RP, Levy MM, Carlet JM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Medicine. 2008;34(1):17–60.
    1. Hernandez G, Bruhn A, Romero C, et al. Management of septic shock with a norepinephrine-based haemodynamic algorithm. Resuscitation. 2005;66(1):63–69.
    1. Hernandez G, Bruhn A, Romero C, et al. Implementation of a norepinephrine-based protocol for management of septic shock: a pilot feasibility study. The Journal of Trauma. 2006;60(1):77–81.
    1. Cornejo R, Downey P, Castro R, et al. High-volume hemofiltration as salvage therapy in severe hyperdynamic septic shock. Intensive Care Medicine. 2006;32(5):713–722.
    1. Castro R, Regueira T, Aguirre ML, et al. An evidence-based resuscitation algorithm applied from the emergency room to the ICU improves survival of severe septic shock. Minerva Anestesiologica. 2008;74(6):223–231.
    1. Marik PE, Monnet X, Teboul JL. Hemodynamic parameters to guide fluid therapy. Annals of Intensive Care. 2011;1, article 1
    1. Malbrain MLNG, Cheatham ML, Kirkpatrick A, et al. Results from the International Conference of Experts on Intra-abdominal Hypertension and Abdominal Compartment Syndrome. I. Definitions. Intensive Care Medicine. 2006;32(11):1722–1732.
    1. De Backer D, Hollenberg S, Boerma C, et al. How to evaluate the microcirculation: report of a round table conference. Critical Care. 2007;11, article R101
    1. van der Poll T, De Boer JDD, Levi M. The effect of inflammation on coagulation and vice versa. Current Opinion in Infectious Diseases. 2011;24(3):273–278.
    1. Vincent JL. Microvascular endothelial dysfunction: a renewed appreciation of sepsis pathophysiology. Critical Care. 2001;5(supplement 2):S1–S5.
    1. Hartemink KJ, Hack CE, Groeneveld ABJ. Relation between coagulation/fibrinolysis and lactate in the course of human septic shock. Journal of Clinical Pathology. 2010;63(11):1021–1026.
    1. Levi M, Löwenberg EC. Thrombocytopenia in critically ill patients. Seminars in Thrombosis and Hemostasis. 2008;34(5):417–424.
    1. Ince C. The microcirculation is the motor of sepsis. Critical Care. 2005;9(4):S13–S19.
    1. Boerma EC, Kuiper MA, Kingma WP, Egbers PH, Gerritsen RT, Ince C. Disparity between skin perfusion and sublingual microcirculatory alterations in severe sepsis and septic shock: a prospective observational study. Intensive Care Medicine. 2008;34(7):1294–1298.
    1. Boerma EC, van der Voort PHJ, Spronk PE, Ince C. Relationship between sublingual and intestinal microcirculatory perfusion in patients with abdominal sepsis. Critical Care Medicine. 2007;35(4):1055–1060.
    1. Trzeciak S, Bajaj J, Guglielmi M. Microcirculatory perfusion in severe sepsis does not correlate with lactate. Critical Care Medicine. 2004;32(12, article A156)
    1. De Backer D, Creteur J, Dubois MJ, et al. The effects of dobutamine on microcirculatory alterations in patients with septic shock are independent of its systemic effects. Critical Care Medicine. 2006;34(2):403–408.
    1. Ospina-Tascon G, Neves AP, Occhipinti G, et al. Effects of fluids on microvascular perfusion in patients with severe sepsis. Intensive Care Medicine. 2010;36(6):949–955.
    1. Dubin A, Pozo MO, Casabella CA, et al. Increasing arterial blood pressure with norepinephrine does not improve microcirculatory blood flow: a prospective study. Critical Care. 2009;13(3, article R92)
    1. Ruiz C, Hernandez G, Godoy C, Downey P, Andresen M, Bruhn A. Sublingual microcirculatory changes during high-volume hemofiltration in hyperdynamic septic shock patients. Critical Care. 2010;14(5, article 170)
    1. Jhanji S, Stirling S, Patel N, Hinds CJ, Pearse RM. The effect of increasing doses of norepinephrine on tissue oxygenation and microvascular flow in patients with septic shock. Critical Care Medicine. 2009;37(6):1961–1966.
    1. Trzeciak S, Dellinger RP, Parrillo JE, et al. Early microcirculatory perfusion derangements in patients with severe sepsis and septic shock: relationship to hemodynamics, oxygen transport, and survival. Annals of Emergency Medicine. 2007;49(1):88–98.e2.
    1. Boerma EC, Koopmans M, Konijn A, et al. Effects of nitroglycerin on sublingual microcirculatory blood flow in patients with severe sepsis/septic shock after a strict resuscitation protocol: a double-blind randomized placebo controlled trial. Critical Care Medicine. 2010;38(1):93–100.

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi